Biblio

Filters: First Letter Of Title is O [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

O

Zorin VL, Komlev VS, Zorina AI, Khromova NV, Solovieva EV, Fedotov AYu, Eremin II, Kopnin PB. Octacalcium phosphate ceramics combined with gingiva-derived stromal cells for engineered functional bone grafts. Biomed Mater. 2014;9(5):055005.

Yang T, Liang N, Zhang J, Bai Y, Li Y, Zhao Z, Chen L, Yang M, Huang Q, Hu P, et al. OCTN2 enhances PGC-1α-mediated fatty acid oxidation and OXPHOS to support stemness in hepatocellular carcinoma. Metabolism. 2023:155628.

Ko DSung, Lee DRyul, Song H, Kim J-H, Lim CKyu. Octylphenol and nonylphenol affect decidualization of human endometrial stromal cells. Reprod Toxicol. 2019.

Bian Y, Jurkunas U. Ocular Chemical Injuries and Limbal Stem Cell Deficiency (LSCD): An Update on Management. Int Ophthalmol Clin. 2024;64(2):31-48.

Singh P, Tyagi M, Kumar Y, Gupta KK, Sharma PD. Ocular chemical injuries and their management. Oman J Ophthalmol. 2013;6(2):83-86.

Jeppesen H, Gjærde LKlingen, Lindegaard J, Julian HOlsen, Heegaard S, Sengeløv H. Ocular Chronic Graft-Versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes After Allogeneic Haematopoietic Cell Transplantation. Transplant Cell Ther. 2022.

Felder-Schmittbuhl M-P, Buhr ED, Dkhissi-Benyahya O, Hicks D, Peirson SN, Ribelayga CP, Sandu C, Spessert R, Tosini G. Ocular Clocks: Adapting Mechanisms for Eye Functions and Health. Invest Ophthalmol Vis Sci. 2018;59(12):4856-4870.

Nandyala S, Mohamed A, Chaurasia S, Kaliki S, Ramappa M, Vemuganti GK. Ocular Features in a Large Cohort of Indians With Xeroderma Pigmentosum. Cornea. 2020.

Nassiri N, Eslani M, Panahi N, Mehravaran S, Ziaei A, Djalilian AR. Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation: A Review of Current Knowledge and Recommendations. J Ophthalmic Vis Res. 2013;8(4):351-358.

Balasubramaniam SC, Raja H, Nau CB, Shen JF, Schornack MM. Ocular Graft-Versus-Host Disease: A Review. Eye Contact Lens. 2015.

Inamoto Y, Valdés-Sanz N, Ogawa Y, Alves M, Berchicci L, Galvin J, Greinix H, Hale GA, Horn B, Kelly D, et al. Ocular graft-versus-host disease after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT. Biol Blood Marrow Transplant. 2018.

Soleimani M, Sharif PMahdavi, Cheraqpour K, Koganti R, Masoumi A, Baharnoori SMahbod, Salabati M, Djalilian AR. Ocular graft-versus-host disease (oGVHD): From A to Z. Surv Ophthalmol. 2023.

Tappeiner C, Heiligenhaus A, Dietrich-Ntoukas T. Ocular Involvement in Graft-versus-Host Disease. Klin Monbl Augenheilkd. 2024.

Fenzl CR, Teramoto K, Moshirfar M. Ocular manifestations and management recommendations of lysosomal storage disorders I: mucopolysaccharidoses. Clin Ophthalmol. 2015;9:1633-1644.

Fan S-X, Wang W-H, Zeng P, Huang K-Z, Hu Y-X, Wang J, Li Y-Q, Xiao J-H. Ocular manifestations and quality of life in patients after hematopoietic stem cell transplantation. Int J Ophthalmol. 2023;16(7):1138-1144.

Ma KSheng-Kai, Saeed HN, Chodosh J, Wang C-W, Chung CYu-Chien, Wei L-C, Kuo M-T, Liang C-M, Chang JWen-Cheng, Chung W-H, et al. Ocular manifestations of anti-neoplastic immune checkpoint inhibitor-associated Stevens-Johnson syndrome/toxic epidermal necrolysis in cancer patients. Ocul Surf. 2021.

Nassar A, Tabbara KF, Aljurf M. Ocular manifestations of graft-versus-host disease. Saudi J Ophthalmol. 2013;27(3):215-22.

Sulyok M, Rózsa L, Bodó I, Tappe D, Hardi R. Ocular Pentastomiasis in the Democratic Republic of the Congo. PLoS Negl Trop Dis. 2014;8(7):e3041.

Iyer G, Srinivasan B, Agarwal S. Ocular Sequelae of Stevens-Johnson Syndrome: A Comprehensive Approach. Cornea. 2020.

Dhamodaran K, Subramani M, Ponnalagu M, Shetty R, Das D. Ocular stem cells: a status update!. Stem Cell Res Ther. 2014;5(2):56.

Lam J, Wong TT, Tong L. Ocular surface disease in posttrabeculectomy/mitomycin C patients. Clin Ophthalmol. 2015;9:187-191.

Kobayashi Y, Hayashi R, Shibata S, Quantock AJ, Nishida K. Ocular surface ectoderm instigated by WNT inhibition and BMP4. Stem Cell Res. 2020;46:101868.

Kennedy DP, Chandler JW, McCulley JP. Ocular surface involvements in ectrodactyly-ectodermal dysplasia-cleft syndrome. Cont Lens Anterior Eye. 2015.

Nibandhe A, Kaliki S, Jakati S, Shanbhag S, Basu S, Donthineni PRao. Ocular surface pseudoepitheliomatous hyperplasia secondary to allergic eye disease: clinical features and management. Eye (Lond). 2023.

Tsai T-Y, Chang H-T, Weng S-W, Chu C-C, Wang Y-C, Zhao Z, Mai ELin-Chin. Ocular surface reconstruction of Steven Johnson syndrome / toxic epidermal necrolysis affected eye - A case report. Heliyon. 2023;9(1):e12590.

Pages